Clinical Trial Update: Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of taurine on glycemic, lipid, and inflammatory markers in adults with type 2 diabetes; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Taurine (taurine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: RECRUITING